Wednesday, November 20, 2024
HomeTagsInterstitial lung disease

interstitial lung disease

Boehringer Ingelheim support the potential use of nintedanib in children

Boehringer Ingelheim announced Phase III data from the InPedILD trial, which assessed the pharmacokinetics (dosing) and safety profile of nintedanib in children and adolescents...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics